Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
san francisco blog main
allergan
alzheimer's disease
astrazeneca
biogen
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
sarepta therapeutics
seattle blog main
seattle top stories
springworks therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
biotech
3
×
bio
research
roundup
abbvie
alliance
alzheimer’s
annual
assessed
attention
august
busy
communities
conference
days
decisions
devices
drug
drugs
editas
editing
esmo
europe
exits
experimental
fda
gene
genetic
germany
hosted
investment
legacy
medicines
munich
news
nods
opioid
pact
partnership
past
Language
unset
Current search:
abbvie
×
biotech
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More